W
Wanjun Qi
Researcher at Nankai University
Publications - 5
Citations - 1148
Wanjun Qi is an academic researcher from Nankai University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications receiving 889 citations.
Papers
More filters
Journal ArticleDOI
Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells
Lei Liu,Du Feng,Guo Chen,Ming Chen,Qiaoxia Zheng,Pingping Song,Qi Ma,Chongzhuo Zhu,Rui Wang,Wanjun Qi,Lei Huang,Peng Xue,Baowei Li,Xiaohui Wang,Haijing Jin,Jun Wang,Fuquan Yang,Pingsheng Liu,Yushan Zhu,Sen-Fang Sui,Quan Chen,Quan Chen +21 more
TL;DR: It is reported that FUNDC1, an integral mitochondrial outer-membrane protein, is a receptor for hypoxia-induced mitophagy, and its findings offer insights into mitochondrial quality control in mammalian cells.
Journal ArticleDOI
Fungal commensalism modulated by a dual-action phosphate transceptor.
Yuanyuan Wang,Jia Zhou,Yun Zou,Xiaoqing Chen,Lin Liu,Wanjun Qi,Xinhua M. Huang,Chang-Shi Chen,Ning-Ning Liu +8 more
TL;DR: In this article , the authors discover that depletion of the phosphate transceptor Pho84 across multiple fungal species encountered a substantial cost in gastrointestinal colonization, but this did not translate into enhanced pathogenicity.
Journal ArticleDOI
Toxoplasma gondii Rhoptry Protein 7 (ROP7) Interacts with NLRP3 and Promotes Inflammasome Hyperactivation in THP-1-Derived Macrophages
TL;DR: Findings unveil that a T. gondii-derived protein is able to promote inflammasome activation, and further study of ROP7 will deepen the understanding of host innate immunity to parasites.
Journal ArticleDOI
A dual action small molecule enhances azoles and overcomes resistance through co-targeting Pdr5 and Vma1: Osimertinib targets Pdr5 and Vma1.
Ning-Ning Liu,Jia Zhou,Tong Jiang,Maureen Tarsio,Feifei Yu,Xuehan Zheng,Wanjun Qi,Lin Liu,Jingcong Tan,Luqi Wei,Jun Ding,Jingquan Li,Lingbing Zeng,Biao Ren,Xiaotian Huang,Yibing Peng,Yong-Bing Cao,Yanbin Zhao,Xin-Yu Zhang,Patricia M. Kane,Chang-Shi Chen,Hui Wang +21 more
TL;DR: In this paper , the specific EGFR inhibitor osimertinib mesylate (OSI) was found to potentiate azole efficacy against diverse fungal pathogens and overcomes azole resistance.
Journal ArticleDOI
Two Pathways Diverge: Glycerophosphocholine Impacts Both Phosphate and Lipid Metabolism in Candida albicans
William Ray King,Maikel Acosta-Zaldívar,Wanjun Qi,Lauren Cooke,Nicholas Cherico,Julia R. Köhler,Jana Patton-Vogt +6 more
TL;DR: Results show that provision of cells with GPC as phosphate source alleviates hypersensitivity of pho84∆/∆ mutants to osmotic, oxidative, and cell wall stress and indicates that C. albicans can utilize the abundant lipid metabolite, GPC, via at least two metabolic pathways to promote its growth and survival in the human host.